- call +1-201-465-4211
- email sales@mrinsights.biz
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments.
Scope of the Report:
This report focuses on the Cancer Molecular Biomarkers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Factors such as technological advancements, increasing research and development activities, increase in funding from various government and non-government organizations, rise in healthcare expenditure, non invasive technology, increasing incidences of cancer, and streamlined drug delivery process are expected to drive the market for cancer molecular biomarkers .In addition, growing survival rates and increased accuracy of diagnosis with the help of biomarkers are expected to drive market for cancer molecular biomarkers.
The worldwide market for Cancer Molecular Biomarkers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Correlogic Systems
AgendiaBv
BioMerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix
Clarient
Biomoda
Beckman Coulter
Dickinson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Genetic Methods
Protein Methods
Imaging
Market Segment by Applications, can be divided into
Pharmaceutical Companies
Medical Laboratory
Hospital
There are 15 Chapters to deeply display the global Cancer Molecular Biomarkers market.
Chapter 1, to describe Cancer Molecular Biomarkers Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cancer Molecular Biomarkers, with sales, revenue, and price of Cancer Molecular Biomarkers, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Molecular Biomarkers, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cancer Molecular Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cancer Molecular Biomarkers sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cancer Molecular Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Genetic Methods
1.2.2 Protein Methods
1.2.3 Imaging
1.3 Market Analysis by Applications
1.3.1 Pharmaceutical Companies
1.3.2 Medical Laboratory
1.3.3 Hospital
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Correlogic Systems
2.1.1 Business Overview
2.1.2 Cancer Molecular Biomarkers Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Correlogic Systems Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AgendiaBv
2.2.1 Business Overview
2.2.2 Cancer Molecular Biomarkers Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AgendiaBv Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 BioMerieux
2.3.1 Business Overview
2.3.2 Cancer Molecular Biomarkers Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMerieux Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Aureon Laboratories
2.4.1 Business Overview
2.4.2 Cancer Molecular Biomarkers Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Aureon Laboratories Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Astellas Pharma US
2.5.1 Business Overview
2.5.2 Cancer Molecular Biomarkers Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Astellas Pharma US Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Becton
2.6.1 Business Overview
2.6.2 Cancer Molecular Biomarkers Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Becton Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Diadexus
2.7.1 Business Overview
2.7.2 Cancer Molecular Biomarkers Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Diadexus Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Abbott Laboratories
2.8.1 Business Overview
2.8.2 Cancer Molecular Biomarkers Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Abbott Laboratories Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Affymetrix
2.9.1 Business Overview
2.9.2 Cancer Molecular Biomarkers Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Affymetrix Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Clarient
2.10.1 Business Overview
2.10.2 Cancer Molecular Biomarkers Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Clarient Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Biomoda
2.11.1 Business Overview
2.11.2 Cancer Molecular Biomarkers Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biomoda Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Beckman Coulter
2.12.1 Business Overview
2.12.2 Cancer Molecular Biomarkers Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Beckman Coulter Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Dickinson
2.13.1 Business Overview
2.13.2 Cancer Molecular Biomarkers Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Dickinson Cancer Molecular Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Molecular Biomarkers Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Molecular Biomarkers Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Molecular Biomarkers Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Molecular Biomarkers Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Molecular Biomarkers Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Molecular Biomarkers Market Analysis by Regions
4.1 Global Cancer Molecular Biomarkers Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Molecular Biomarkers Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Molecular Biomarkers Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
4.5 South America Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
5 North America Cancer Molecular Biomarkers by Countries
5.1 North America Cancer Molecular Biomarkers Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Molecular Biomarkers Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Molecular Biomarkers Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
6 Europe Cancer Molecular Biomarkers by Countries
6.1 Europe Cancer Molecular Biomarkers Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Molecular Biomarkers Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Molecular Biomarkers Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
6.3 UK Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
6.4 France Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Molecular Biomarkers by Countries
7.1 Asia-Pacific Cancer Molecular Biomarkers Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Molecular Biomarkers Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Molecular Biomarkers Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
7.5 India Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
8 South America Cancer Molecular Biomarkers by Countries
8.1 South America Cancer Molecular Biomarkers Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Molecular Biomarkers Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Molecular Biomarkers Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Molecular Biomarkers by Countries
9.1 Middle East and Africa Cancer Molecular Biomarkers Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Molecular Biomarkers Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Molecular Biomarkers Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Molecular Biomarkers Sales and Growth Rate (2013-2018)
10 Global Cancer Molecular Biomarkers Market Segment by Type
10.1 Global Cancer Molecular Biomarkers Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Molecular Biomarkers Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Molecular Biomarkers Revenue and Market Share by Type (2013-2018)
10.2 Genetic Methods Sales Growth and Price
10.2.1 Global Genetic Methods Sales Growth (2013-2018)
10.2.2 Global Genetic Methods Price (2013-2018)
10.3 Protein Methods Sales Growth and Price
10.3.1 Global Protein Methods Sales Growth (2013-2018)
10.3.2 Global Protein Methods Price (2013-2018)
10.4 Imaging Sales Growth and Price
10.4.1 Global Imaging Sales Growth (2013-2018)
10.4.2 Global Imaging Price (2013-2018)
11 Global Cancer Molecular Biomarkers Market Segment by Application
11.1 Global Cancer Molecular Biomarkers Sales Market Share by Application (2013-2018)
11.2 Pharmaceutical Companies Sales Growth (2013-2018)
11.3 Medical Laboratory Sales Growth (2013-2018)
11.4 Hospital Sales Growth (2013-2018)
12 Cancer Molecular Biomarkers Market Forecast (2018-2023)
12.1 Global Cancer Molecular Biomarkers Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Molecular Biomarkers Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Molecular Biomarkers Market Forecast (2018-2023)
12.2.2 Europe Cancer Molecular Biomarkers Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Molecular Biomarkers Market Forecast (2018-2023)
12.2.4 South America Cancer Molecular Biomarkers Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Molecular Biomarkers Market Forecast (2018-2023)
12.3 Cancer Molecular Biomarkers Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Molecular Biomarkers Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Molecular Biomarkers Market Share Forecast by Type (2018-2023)
12.4 Cancer Molecular Biomarkers Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Molecular Biomarkers Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Molecular Biomarkers Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cancer Molecular Biomarkers Picture
Table Product Specifications of Cancer Molecular Biomarkers
Figure Global Sales Market Share of Cancer Molecular Biomarkers by Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
